Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.00
Bid: 31.50
Ask: 32.50
Change: 0.50 (1.59%)
Spread: 1.00 (3.175%)
Open: 31.50
High: 32.00
Low: 31.50
Prev. Close: 31.50
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Retail Offer and Open Offer Details

7 Oct 2019 07:00

RNS Number : 9067O
Duke Royalty Limited
07 October 2019
 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR FROM THE UNTIED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT DOES NOT CONSTITUTE A PROSPECTUS OR OFFERING MEMORANDUM IN RESPECT OF ANY SECURITIES.

 

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Result of Retail Offer and announcement of Open Offer details

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, recently announced a Fundraising of up to approximately £20 million from new and existing investors, which included a Placing, a Retail Offer (the "Retail Offer"), and an Open Offer.

The Company is pleased to announce that it has successfully completed the Retail Offer and has conditionally raised a total of approximately £461,500 on the platform, through the issue of 1,048,974 New Ordinary Shares to be issued on Admission. To date, the total of the Placing and Retail Offer has raised approximately £16.55 million.

As such, up to approximately £3.45 million will be available to Qualifying Shareholders under the Open Offer through the issue of up to 7,838,135 Open Offer Shares. As previously announced, the Company will also seek further direct subscriptions of new Ordinary Shares to accommodate demand from new and existing investors, including family offices and private wealth managers.

The Company will announce the final amount raised pursuant to the Fundraising, and any additional subscriptions of new Ordinary Shares near the time of the General Meeting.

Qualifying Shareholders may apply for Open Offer Shares under the Open Offer at the Issue Price on the following basis:

2 Open Offer Shares for every 51 Existing Ordinary Shares

and so in proportion for any number of Existing Ordinary Shares held on the Record Date. Entitlements of Qualifying Shareholders will be rounded down to the nearest whole number of Offer Shares. Fractional entitlements which would otherwise arise will not be issued to the Qualifying Shareholders but will be made available under the Excess Application Facility. The Excess Application Facility enables Qualifying Shareholders to apply for Excess Shares in excess of their Open Offer Entitlement. Not all Shareholders will be Qualifying Shareholders. Shareholders who are located in, or are citizens of, or have a registered office in certain overseas jurisdictions will not qualify to participate in the Open Offer.

Further details of the Open Offer are to be included in a Circular to Shareholders which it is expected to be posted to Shareholders shortly. The expected Open Offer timetable was recently announced by the Company and is also contained within the Circular.

The Fundraising remains conditional, inter alia, upon:

(a) the Extraordinary Resolution having been passed by the requisite majority of Shareholders at the Extraordinary General Meeting;

(b) the Placing Agreement having become unconditional in all respects and not having been terminated in accordance with its terms prior to Admission; and

(c) Admission becoming effective not later than 8.00 a.m. on 31 October 2019 or such later time and/or date as the Company and Cenkos may agree, being not later than 8.00 a.m. on 14 November 2019.

If any of the conditions are not satisfied, the Offer Shares will not be issued and all monies received from the investors will be returned to the investors (at the investors' risk and without interest) as soon as possible thereafter. The Retail Offer and the Open Offer are not being underwritten.

Unless otherwise defined, capitalised terms shall have the meaning as those set out in the 'Definitions' section of the announcement issued by the Company on 4 October 2019.

 

 

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes

 

+44 (0) 1481 741 240

Cenkos Securities plc 

(Nominated Adviser and Broker)

 

Julian Morse / Michael Johnson / Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

Edison Investment Research Limited

Elliott Berstock

+44 (0) 20 3077 5700

PrimaryBid Limited

Kieran D'Silva

 

+44 (0) 20 3026 4750

Newgate Communications

(PR)

 

Elisabeth Cowell / Ian Silvera / Megan Kovach

+44 (0) 20 3757 6880

Dukeroyalty@newgatecomms.com

 

 

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 Important Notice

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by or on behalf of the Company, Cenkos Securities plc or by their affiliates or their respective agents, directors, officers and employees as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed.

 

The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser.

 

The New Ordinary Shares will not be admitted to trading on any stock exchange other than the AIM Market of the London Stock Exchange.

 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

 

 

 

**ENDS**

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPDDBDGXSGBGCL
Date   Source Headline
14th Mar 20197:00 amRNSChange of Adviser
19th Feb 20197:00 amRNSNew Royalty Finance Agreement
5th Feb 20191:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSAcquisition of UK royalty finance provider
17th Dec 20187:00 amRNSFollow-on contribution to royalty partner
5th Dec 20187:00 amRNSIssue of Shares and Total Voting Rights
4th Dec 20187:00 amRNSInterim results and dividend declaration
27th Nov 201811:31 amRNSDuke Royalty to Present at Mello London
31st Oct 20187:00 amRNSLTIP Awards and other Issuances
30th Oct 20187:00 amRNSOperational and Corporate Update
28th Sep 20187:00 amRNSFurther Contribution to Royalty Partner
24th Sep 20187:00 amRNSFinal Results and Notice of AGM
20th Sep 20187:00 amRNSDividend Declaration and Notice of Results
30th Aug 20187:00 amRNSNew Royalty Agreement
6th Aug 20184:50 pmRNSNotification of major holdings
6th Aug 20184:45 pmRNSNotification of major holdings
6th Aug 20183:18 pmRNSHolding(s) in Company
6th Aug 20181:18 pmRNSNotification of Major Holdings
2nd Aug 201812:20 pmRNSResult of EGM and Issue of Equity
16th Jul 20187:00 amRNSFundraising to raise £44m and EGM announcement
13th Jul 20184:56 pmRNSFundraising to raise £44 million and notice of EGM
19th Jun 20187:00 amRNSInterim Dividend Increase
14th Jun 20187:01 amRNSRoyalty finance agreement LOI and secured loan
14th Jun 20187:00 amRNSUpdate on Exclusive Collaboration
8th May 20187:00 amRNSOperational Update on Royalty Partners
26th Apr 20187:00 amRNSFurther Contribution to Royalty Partner
24th Apr 20187:00 amRNSNew Royalty Agreement
16th Apr 20181:34 pmRNSDuke Royalty at Berenberg UK Corporate Conference
13th Mar 20187:00 amRNSInterim Dividend Increase & Dividend Declaration
8th Mar 20187:00 amRNSDirector/PDMR Shareholdings
6th Mar 20187:00 amRNSLong Term Incentive Plan Awards
5th Mar 20187:00 amRNSNew Royalty Finance Agreement
27th Feb 20187:00 amRNSDuke Royalty Appoints Redleaf Communications
2nd Jan 20184:51 pmRNSHolding(s) in Company
22nd Dec 201712:09 pmRNSHolding(s) in Company
21st Dec 201710:36 amRNSResult of EGM and Issue of Equity
19th Dec 201712:49 pmRNSInterim Dividend
5th Dec 20173:18 pmRNSResult of the Fundraising and Notice of EGM
4th Dec 20174:48 pmRNSProposed Fundraising to raise at least £20 million
13th Nov 20179:39 amRNSFurther Contribution to Royalty Partner
8th Nov 20177:05 amRNSUnaudited Interim Results
8th Nov 20177:00 amRNSStrategic Advisory Agreement
9th Oct 201711:01 amRNSDirector/PDMR Shareholding
6th Oct 20177:00 amRNSNew Royalty Finance Agreement
28th Sep 20172:47 pmRNSBoard changes and investment team addition
27th Sep 201711:46 amRNSResult of AGM
21st Sep 20173:14 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSChange of Adviser and Interim Dividend
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.